[PAPILLARY THYROID CARCINOMA RESPONDS TO CDK 4/6 INHIBITORS].

Drozdov, Kiril; Popovits-Hadari, Noa; Leviov, Michelle; Sikorsky, Natalia; Shulman, Katerina

Drozdov, Kiril; Popovits-Hadari, Noa; Leviov, Michelle; Sikorsky, Natalia; Shulman, Katerina.

Afiliación

Drozdov K; Oncology Institute, Lin Medical Center and Carmel Hospital, Clalit Health Care Services, Haifa, Israel.
Popovits-Hadari N; Oncology Institute, Lin Medical Center and Carmel Hospital, Clalit Health Care Services, Haifa, Israel.
Leviov M; Marvelle Koffler Breast Centre, Mt. Sinai Hospital.
Sikorsky N; Princess Margaret Hospital, Toronto, ON Canada.
Shulman K; Oncology Institute, Lin Medical Center and Carmel Hospital, Clalit Health Care Services, Haifa, Israel.

Harefuah ; 161(1): 30-33, 2022 Jan.

Article en He | MEDLINE | ID: mdl-35077057

Asunto(s)

Neoplasias de la Mama; Carcinoma Papilar; Neoplasias de la Tiroides; Neoplasias de la Mama/tratamiento farmacológico; Femenino; Humanos; Cáncer Papilar Tiroideo/diagnóstico; Neoplasias de la Tiroides/diagnóstico; Neoplasias de la Tiroides/tratamiento farmacológico

Buscar en Google

Imprimir

XML

PubMed Links

Banco de datos: MEDLINE Asunto principal: Neoplasias de la Mama / Neoplasias de la Tiroides / Carcinoma Papilar Tipo de estudio: Diagnostic_studies / Guideline / Risk_factors_studies Límite: Female / Humans Idioma: He Año: 2022 Tipo del documento: Article

Buscar en Google

Imprimir

XML

PubMed Links